Freshpet (FRPT)
NASDAQConsumer StaplesPackaged FoodsSnapshot 2026-10-29
$67.50+2.09%
Close 2026-10-30 · 1-day change
NASDAQConsumer StaplesPackaged FoodsSnapshot 2026-10-29
Research Workspace
Put FRPT beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Packaged Foods & Meats is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Management is running behind on a stated commitment.
View ThesisRevenue growth is slowing — up about 13% over the past year and decelerating.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 35%, softest on share dilution.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look high — the market is pricing in about 82% growth a year, above the roughly 11% analysts expect, leaving little room for error.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 45% in its worst 12-month stretch.
View RiskFRPT’s case rests on steady sales growth, though its valuation prices in more growth than we forecast. Revenue growth rose from 13.1% to 15.5% year over year. Q2 FY2026 GAAP earnings beat consensus. FRPT trades at 22× P/E versus a 13× peer median. The market’s full growth expectations leave that premium vulnerable to compression. Management is running behind on a stated commitment. Our model puts the next-quarter miss probability near 17%. Peer multiples imply a price about 82% below where it trades; the thesis is on watch, and this read is provisional.
Trailing returns as of 2026-10-30. FRPT is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 18 analysts currently covering FRPT (as of Oct 2026).
Based on 3 Wall Street analysts offering 12-month price targets for FRPT in the last 4 months.
Continue this research
Compare FRPT with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| FRPT Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 8 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Packaged Foods & Meats — fair value, gap to price, and forward P/E.
Compare the value case
Put FRPT next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Increase revenue growth
Strong growth aligns with revenue growth objective.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $67.50
The last 12 months of price, then the range of analyst 12-month targets from today’s $67.50.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Improve gross profit margins
Targeted gross margin supports margin improvement goal.
Advances: Increase revenue growth
Strong sales directly support revenue growth objective.
Co-founder departure may impact strategic direction.
Advances: Increase revenue growth
CEO's growth expectations support revenue growth objective.